INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 133 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $421,000 | -30.4% | 84,437 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $605,000 | -22.7% | 84,437 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $783,000 | -0.1% | 84,437 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $784,000 | -3.3% | 84,437 | -7.9% | 0.00% | -25.0% |
| Q4 2020 | $811,000 | -23.7% | 91,671 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $1,063,000 | -19.0% | 91,671 | +88.2% | 0.01% | -14.3% |
| Q2 2020 | $1,313,000 | +91.7% | 48,710 | -47.1% | 0.01% | +40.0% |
| Q1 2020 | $685,000 | +1.2% | 92,122 | -55.1% | 0.01% | +25.0% |
| Q4 2019 | $677,000 | +61.2% | 205,045 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $420,000 | -30.3% | 205,045 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $603,000 | -28.0% | 205,045 | -8.8% | 0.00% | -25.0% |
| Q1 2019 | $838,000 | -6.8% | 224,765 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $899,000 | -17.4% | 224,765 | +14.9% | 0.01% | 0.0% |
| Q3 2018 | $1,088,000 | +185.6% | 195,629 | +101.3% | 0.01% | +150.0% |
| Q2 2018 | $381,000 | -16.8% | 97,196 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $458,000 | +4.3% | 97,196 | -8.6% | 0.00% | 0.0% |
| Q4 2017 | $439,000 | -34.9% | 106,384 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $674,000 | -59.6% | 106,384 | -50.0% | 0.00% | -20.0% |
| Q2 2017 | $1,668,000 | +346.0% | 212,768 | +276.7% | 0.01% | +150.0% |
| Q1 2017 | $374,000 | +0.3% | 56,487 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $373,000 | -29.1% | 56,487 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $526,000 | +0.8% | 56,487 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $522,000 | +6.1% | 56,487 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $492,000 | +20.6% | 56,487 | -7.0% | 0.00% | 0.0% |
| Q4 2015 | $408,000 | +16.2% | 60,731 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $351,000 | -29.2% | 60,731 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $496,000 | 0.0% | 60,731 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $496,000 | -11.1% | 60,731 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $558,000 | – | 60,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |